Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between Alzheimer's disease, MAPT gene mutation and some biochemical biomarkers.

Nucleosides, nucleotides & nucleic acids - 1 Jan 2024

Sen Aysenur, Avsar Orcun, Eliacik Sinan, Uysal Tan Funda

Abstract excerpt

Alzheimer's Disease (AD) is a multifactorial neurodegenerative disease and there is still no definitive treatment today. Early diagnosis of the disease is important, but there are almost no biomarkers that can be used in early diagnosis. The cerebrospinal fluid used in the diagnosis of the disease is not sufficient and is very difficult to obtain. Therefore, blood biomarkers that are less costly, less invasive,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alzheimer Disease
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Folic Acid

Share to Homocysteine

Share to tau Proteins

Share to Uric Acid

Source

Identifiers

PMID: 38319996
DOI: 10.1080/15257770.2024.2313573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between Alzheimer's disease, MAPT gene mutation and some biochemical biomarkers.PMID 38319996Read ↗

A Case of Early-Onset Alzheimer's Disease with MAPT P301L Mutation and Literature ReviewSemantic proximity Read ↗

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.Semantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Association of Biochemical Parameters and Screening for Mutations in the MCU Gene in Alzheimer's Disease Patients.Semantic proximity Read ↗

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Semantic proximity Read ↗

Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms.Semantic proximity Read ↗

MTHFR gene A1298C polymorphism and Alzheimer’s disease susceptibilitySemantic proximity Read ↗

Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer disease does not share a common founder in Western EuropeSemantic proximity Read ↗

Association ofMAPThaplotype‐tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: A preliminary study in a Croatian cohortSemantic proximity Read ↗

MTHFR Gene Mutations: A Potential Marker of Late-Onset Alzheimer's Disease?Semantic proximity Read ↗

The methylenetetrahydrofolate reductase C677T and A1298C genetic polymorphisms and plasma homocysteine in Alzheimer's disease in an Algerian population.Semantic proximity Read ↗

Genetic effect of MTHFR C677T, A1298C, and A1793G polymorphisms on the age at onset, plasma homocysteine, and white matter lesions in Alzheimer's disease in the Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.